Christopher Hite sold $7.3M of Royalty Pharma (RPRX)

Executed Jun 30, disclosed Jul 2, 2 days later.

Value, as filed

$7.3M

129,400 sh across 3 lots

Executed

Jun 30

the trade date, as filed

Disclosed

Jul 2

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Hite EVP & Chairman, Partnering profile →

Christopher Hite (EVP & Chairman, Partnering) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Royalty Pharma plc (RPRX). The largest single filing was $8.2M of RPRX (150,000 sh across 2 lots, as filed), executed Jun 23.

The name

RPRX

Royalty Pharma plc RPRX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the U…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Hite in RPRX

RPRXSALE Royalty Pharma plc $6.0M
100,000 sh × $59.97
Exec Aug 18
Filed Aug 19 · 4:20 PM ET RPRXSALE Royalty Pharma plc $8.2M
150,000 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET